• 21st century bio leading company

    Developing immunoblot-based proteome analysis technology and antibody detection technology for analysis

T-Mac's antibody collection selected for immunoblotting

It consists of commercial antibodies and self-developed antibodies that have been rigorously verified by T-Mac.
It can be used for the MiRIA 2 system for analyzing samples using tens to hundreds of kinds of antibodies simultaneously, or for studies using general immunoblots.
A variety of antibody collection sets for purposes are constructed and provided such as protein analysis, intracellular protein network analysis, specific disease-related studies, etc.



New antibody development plan

Together with the Korea Research Institute of Bioscient & Biotechnology, T-Mac has established a single antibody development technology and recombinant antibody development technology using phage display.
We are developing new antibodies for protein targets that are not covered by current commercial antibodies.